SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $71,947 | -55.0% | 522 | -57.7% | 0.01% | -59.3% |
| Q4 2022 | $160,031 | -4.7% | 1,235 | -18.9% | 0.03% | -22.9% |
| Q3 2022 | $168,000 | +14.3% | 1,522 | -22.1% | 0.04% | +25.0% |
| Q2 2022 | $147,000 | -34.4% | 1,955 | -31.7% | 0.03% | -31.7% |
| Q1 2022 | $224,000 | -13.2% | 2,863 | 0.0% | 0.04% | -18.0% |
| Q4 2021 | $258,000 | -5.8% | 2,863 | -3.3% | 0.05% | -13.8% |
| Q3 2021 | $274,000 | +16.1% | 2,961 | -2.3% | 0.06% | +16.0% |
| Q2 2021 | $236,000 | +95.0% | 3,032 | +86.1% | 0.05% | +85.2% |
| Q1 2021 | $121,000 | +31.5% | 1,629 | +202.8% | 0.03% | +17.4% |
| Q4 2020 | $92,000 | -34.8% | 538 | -46.3% | 0.02% | -46.5% |
| Q3 2020 | $141,000 | -11.9% | 1,001 | 0.0% | 0.04% | -20.4% |
| Q2 2020 | $160,000 | +63.3% | 1,001 | 0.0% | 0.05% | +35.0% |
| Q1 2020 | $98,000 | -26.3% | 1,001 | -3.4% | 0.04% | -41.2% |
| Q4 2019 | $133,000 | – | 1,036 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |